Glaxosmithkline Pharmaceuticals Ltd.

₹2545.6

Glaxosmithkline Pharmaceuticals Ltd.

Add Alert
Add Watchlist

₹2545.6

₹2545.6

34.8 (1.39%) - 6 Dec 2025 04:26 PM

About Company

Glaxosmithkline Pharmaceuticals Limited is engaged in research, manufacture and make available a broad range of medicines and vaccines that benefit people. The company’s Pharmaceuticals business has a broad portfolio of innovative and established medicines with commercial leadership in anti-infectives and dermatology. Its R&D approach focuses on science related to the immune system, use of genetics and advanced technologies. Meanwhile, Its Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. The company is the leaders in India in the private segment.

Market Cap. ₹ 46,466 Cr.
52 Week - High/Low ₹ 3,516/1,921
P/E Ratio 49.19
P/B Ratio 23.78
Enterprise Value ₹ 45,054 Cr.
ROE % 48.92
RSI Value 47.73
EMA 50 2807.67
EMA 200 2788.99
Market Cap. ₹ 46,466 Cr.
52 Week - High/Low ₹ 3,516/1,921
P/E Ratio 48.77
P/B Ratio 23.75
Enterprise Value ₹ 45,052 Cr.
ROE % 49.43
RSI Value 47.73
EMA 50 2807.67
EMA 200 2788.99

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.